1 / 11

Hepatocellular Carcinoma Market

Hepatocellular carcinoma (HCC) is the most common type of liver cancer, and, also a leading cause of cancer-related death worldwide.<br>

DelveInsight
Télécharger la présentation

Hepatocellular Carcinoma Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hepatocellular Carcinoma (HCC) Market Insights, Epidemiology and Market Forecast-2027

  2. Hepatocellular Carcinoma (HCC) Hepatocellular carcinoma (HCC) is the most common type of liver cancer, and, also a leading cause of cancer-related death worldwide. 01 02 Half of all cases of HCC are associated with hepatitis B virus infection, with a further 25% associated with hepatitis C virus. 03 04 The disease is found to be more common in males as compared to females. The incidence and subsequent mortality of the disease is on a continuous upsurge despite gradually improving treatment. • DelveInsight © 2018 | All rights reserved

  3. Cases of (HCC) The total incident cases of HCC in the G8 countries i.e., the United States, EU-5 countries (Germany, France, Italy, Spain and the U.K.), Japan and China, were found to be 4,58,170 in 2016, while the corresponding diagnosed advanced HCC cases in the G8 countries were found to be 1, 60,565 for the same year. • DelveInsight © 2018 | All rights reserved

  4. Market Outlook The analysis conducted for the period of 2016-2027, the market size of Hepatocellular Carcinoma is expected to reach USD 3.8 Billion in 2027 for the G8 countries. The United States had the highest market share of HCC in 2016, as compared to the EU5 countries (Germany, France, Italy, Spain & UK) Japan and China. Among the EU5 countries, Italy accounted for the highest market size, while the UK had the lowest market in 2016. • DelveInsight © 2018 | All rights reserved

  5. Emerging Therapies (Companies) TECENTRIQ WITH AVASTIN (Drugs) CABOZANTINIB RAMUCIRUMAB LENVIMA • DelveInsight © 2018 | All rights reserved

  6. Report HCC Report Insights Hcc Report Key Strengths Hcc Report Assessment • Patient Population • Therapeutic Approaches • Pipeline Analysis • Market Size and Trends • Market Opportunities • Impact of upcoming Therapies • 10 Year Forecast •  G8 Coverage •  Epidemiology Segmentation •  Drugs Uptake •  Highly Analyzed Market •  Key Cross Competition • Current Treatment Practices • Unmet Needs • Detailed Pipeline Product Profiles • Market Attractiveness • Market Drivers and Barriers HCC Report Insights Hcc Report Key Strengths Hcc Report Assessment • DelveInsight © 2018 | All rights reserved

  7. Complete Information For complete information on Hepatocellular Carcinoma (HCC) Market Insights, Epidemiology and Market Forecast-2027 please click the link below CLICK HERE OR Write Us At  info@delveinsight.com • DelveInsight © 2018 | All rights reserved

  8. About DelveInsight Mission 2 1 3 About To provide “insights across the value chain” and helping the organization to take a prudent business decision through the use and analysis of actionable market intelligence. The mission also is to provide the most effective result and efficient service with utmost client care for maintaining a long-term relationship with them. Vision DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors. To be the most trusted market research & business consulting firm in the world; and to continue enable the Pharma & Bio-Tech companies to achieve their goals with the best strategic insight and competitive solution. The vision also is inclusive of becoming a one-stop solution provider for the entire gamut of drug development process. • DelveInsight © 2018 | All rights reserved

  9. Service Offerings by DelveInsight 2 8 3 1 6 4 5 7 Market Intelligence Opportunity Assessment Forecasting Socialytics Competitive Analysis Pipeline Consulting Report Store • DelveInsight © 2018 | All rights reserved

  10. Contact Us info@delveinsight.com +91-11-4568 9769 www.delveinsight.com blog/delveInsight/ twitter/delveInsight LinkedIn/delveInsight • DelveInsight © 2018 | All rights reserved

More Related